Aktionsplan Artiva Biotherapeutics, Inc.
Erweiterter Zeitplan
Einfaches Diagramm
Über das Unternehmen Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. The company's lead product candidate is AB-101, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody-associated vasculitis subtypes granulomatosis with polyangiitis/microscopic polyangiitis, systemic lupus erythematosus, and B-cell-non-Hodgkin lymphoma. weitere details| IPO date | 2024-07-19 |
|---|---|
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.artivabio.com |
| Цена ао | 3.64 |
| Preisänderung pro Tag: | 0% (2.35) |
|---|---|
| Preisänderung pro Woche: | +18.09% (1.99) |
| Preisänderung pro Monat: | -59.97% (5.87) |
| Preisänderung über 3 Monate: | -66.99% (7.12) |
| Preisänderung über sechs Monate: | -81.61% (12.78) |
| Preisänderung seit Jahresbeginn: | -78.85% (11.11) |
|
|
Unterschätzung
|
Effizienz
|
|||||||||||||||||||||||||||||||||||||
Dividenden
|
Pflicht
|
Wachstumsimpuls
|
|||||||||||||||||||||||||||||||||||||
| Aufsicht | Berufsbezeichnung | Zahlung | Geburtsjahr |
|---|---|---|---|
| Dr. Fred Aslan M.D. | President, CEO & Director | 1975 (50 Jahre) | |
| Dr. Peter Flynn Ph.D. | Co-Founder & Strategic Advisor | 1974 (51 Jahr) | |
| Ms. Jennifer Kinsbruner Bush Esq., J.D. | Executive VP, COO, Chief Legal Officer, Corporate Secretary & Compliance Officer | 1975 (50 Jahre) | |
| Mr. Christopher P. Horan | Chief Technical Operations Officer | 1967 (58 Jahre) | |
| Ms. Neha Krishnamohan | CFO & Executive VP of Corporate Development | 1987 (38 Jahre) | |
| Dr. Thorsten Graef M.D., Ph.D. | Chief Medical Officer | 1976 (49 Jahre) | |
| Dr. Heather Raymon Ph.D. | Senior Vice President of Research & Early Development | 1964 (61 Jahr) | |
| Mr. Eugene Helsel | Senior Vice President of Regulatory Affairs | ||
| Dr. K. C Lim Pharm.D. | Senior Vice President of Clinical Operations |
Adresse: United States, San Diego, 5505 Morehouse Drive - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.artivabio.com
Webseite: https://www.artivabio.com
